Nanofibrous bionic scaffolds promote cardiomyocyte differentiation of induced pluripotent stem cells

Xiong-tao LIU,Yan CHEN,Di ZENG,Jun LI,Cheng LIAN,Qiang-sun ZHENG
DOI: https://doi.org/10.13191/j.chj.2018.0009
2018-01-01
Abstract:AIM To explore the viability and the potential role of bionic scaffolds on cardiomyocyte (CM) differentiation of induced pluripotent stem cells (iPSCs).METHODS Oct4-GFP + mouse iPSCs (iPSCs) were cultured on poly-(ε-caprolactone)/Gelatin (PCL/Gelatin) composite nanofibrous bionic scaffolds,which were fabricated by an electrospinning technique and were differentiated spontaneously for 15 days.Oct4-GFP + mouse iPSCs (iPSCs) cultured on tissue culture plates (TCPs) were used as control.The development of CMs was verified by immunofluorescence staining of cardiac specific markers,such as cardiac Troponin T (cTnT) and myosin light chain 2a (MLC2a).The efficiency of iPSC-derived-CMs was calculated by flowcytometric analysis.RESULTS The results demonstrated that Oct4-GFP + iPSCs proliferated on the PCL/Gelatin composite nanofibrous scaffold and grew in colonies during the spontaneous differentiation period.Immunofluorescence staining after differentiation for 15 days revealed that some of the iPSCs-derived cells were co-labeled with cTnT and MLC2a.Moreover,flowcytometric analysis demonstrated that the ratio of cTnT +-cells derived from iPSCs was significantly higher in PCL/Gelatin scaffolds than in controls (P < 0.05).CONCLUSION These results suggest that the PCL/Gelatin composite nanofibrous bionic scaffold could support the proliferation and cardiomyocyte differentiation of Oct4-GFP + iPSC and could be potentially used as a platform for myocardium tissue engineering.
What problem does this paper attempt to address?